Related Experiment Videos

Re-examination of [3H]mepyramine binding assay for histamine H1 receptor using quinine

Y Q Liu1, Y Horio, H Mizuguchi

  • 1Department of Pharmacology II, Faculty of Medicine, Osaka University, Suita, Japan.

Insights

[3H]Mepyramine binds the histamine H1 receptor, not mepyramine binding protein (MBP). A new method distinguishes H1 receptor and MBP levels, revealing MBP

Area of Science:

  • Biochemistry
  • Pharmacology
  • Neuroscience

Background:

  • [3H]Mepyramine is a key radioligand for histamine H1 receptor studies.
  • A previously purified mepyramine binding protein (MBP) shares sequence similarity with cytochrome P450 isozymes.
  • Histamine H1 receptor and MBP binding characteristics needed clarification.

Purpose of the Study:

  • To differentiate [3H]mepyramine binding between the histamine H1 receptor and MBP.
  • To develop a method for quantifying H1 receptor and MBP levels.
  • To investigate MBP distribution in bovine brain.

Main Methods:

  • Utilized cloned histamine H1 receptor cDNA for binding studies.
  • Employed quinine, an inhibitor of debrisoquine 4-hydroxylase isozymes, to differentiate binding.
  • Developed a quantitative assay using [3H]mepyramine and quinine.

Main Results:

  • [3H]Mepyramine selectively binds the histamine H1 receptor, not MBP, in the presence of quinine.
  • A method was established to quantify H1 receptor and MBP levels separately.
  • MBP was found to be abundant in specific regions of the bovine brain.

Conclusions:

  • Quinine effectively distinguishes [3H]mepyramine binding to H1 receptors from MBP.
  • The developed method allows for separate quantification of H1 receptors and MBP.
  • MBP exhibits significant regional distribution in the bovine brain, suggesting potential functional roles.

Related Concept Videos